REVIEW
|
doi:10.20944/preprints201903.0256.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
immunocheckpoint inhibitors; chemotherapy; tirosin kinase inhibitors; angiogenesis
Online: 28 March 2019 (06:48:37 CET)
REVIEW
|
doi:10.20944/preprints201909.0071.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Sorafenib; hepatocellular carcinoma; prognostic factors; predicitve factors
Online: 6 September 2019 (10:32:29 CEST)
REVIEW
|
doi:10.20944/preprints201909.0026.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
antiandrogen; bisphosphonates; bone niche; immune system; osteoimmunology; RankL; targeted therapy
Online: 2 September 2019 (16:34:22 CEST)
CASE REPORT
|
doi:10.20944/preprints201905.0173.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Pancreatic ductal adenocarcinoma; non small cell lung cancer; double primary cancers; B7-H3; gefitinib; chemotherapy
Online: 14 May 2019 (13:04:44 CEST)
REVIEW
|
doi:10.20944/preprints201909.0140.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
hepatocellular carcinoma; immune checkpoint inhibitors; HCC; pembrolizumab; nivolumab; immune microenvironment; targeted therapies
Online: 14 September 2019 (18:37:29 CEST)